| Year |
Citation |
Score |
| 2015 |
Wadhwa S, Mumper RJ. Polymer-Drug Conjugates for Anticancer Drug Delivery. Critical Reviews in Therapeutic Drug Carrier Systems. 32: 215-45. PMID 26080809 DOI: 10.1615/Critrevtherdrugcarriersyst.2015010174 |
0.334 |
|
| 2014 |
Madden AJ, Rawal S, Sandison K, Schell R, Schorzman A, Deal A, Feng L, Ma P, Mumper R, DeSimone J, Zamboni WC. Evaluation of the efficiency of tumor and tissue delivery of carrier-mediated agents (CMA) and small molecule (SM) agents in mice using a novel pharmacokinetic (PK) metric: relative distribution index over time (RDI-OT). Journal of Nanoparticle Research : An Interdisciplinary Forum For Nanoscale Science and Technology. 16. PMID 26392803 DOI: 10.1007/S11051-014-2662-1 |
0.337 |
|
| 2014 |
Mumper RJ, Rolland A. 8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 46-8. PMID 25356478 DOI: 10.1016/J.Jconrel.2014.07.020 |
0.35 |
|
| 2014 |
Peng L, Schorzman AN, Ma P, Madden AJ, Zamboni WC, Benhabbour SR, Mumper RJ. 2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model. International Journal of Nanomedicine. 9: 3601-10. PMID 25114529 DOI: 10.2147/Ijn.S66040 |
0.445 |
|
| 2014 |
Peng L, Feng L, Yuan H, Benhabbour SR, Mumper RJ. Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1497-506. PMID 24709328 DOI: 10.1016/J.Nano.2014.03.016 |
0.38 |
|
| 2014 |
Tsuruta JK, Klauber-DeMore N, Streeter J, Samples J, Patterson C, Mumper RJ, Ketelsen D, Dayton P. Ultrasound molecular imaging of secreted frizzled related protein-2 expression in murine angiosarcoma. Plos One. 9: e86642. PMID 24489757 DOI: 10.1371/Journal.Pone.0086642 |
0.3 |
|
| 2013 |
Ma P, Mumper RJ. Paclitaxel Nano-Delivery Systems: A Comprehensive Review. Journal of Nanomedicine & Nanotechnology. 4: 1000164. PMID 24163786 DOI: 10.4172/2157-7439.1000164 |
0.516 |
|
| 2013 |
Zhang Y, Peng L, Mumper RJ, Huang L. Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. Biomaterials. 34: 8459-68. PMID 23932296 DOI: 10.1016/J.Biomaterials.2013.07.050 |
0.417 |
|
| 2013 |
Ma P, Mumper RJ. Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review. Nano Today. 8: 313-331. PMID 23888183 DOI: 10.1016/J.Nantod.2013.04.006 |
0.44 |
|
| 2013 |
Feng L, Benhabbour SR, Mumper RJ. Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancer. Advanced Healthcare Materials. 2: 1451-7. PMID 23606545 DOI: 10.1002/Adhm.201300017 |
0.433 |
|
| 2013 |
Zhang Y, Sadgrove MP, Sueda K, Yang YT, Pacyniak EK, Kagel JR, Braun BA, Zamboni WC, Mumper RJ, Jay M. Nonaqueous gel for the transdermal delivery of a DTPA penta-ethyl ester prodrug. The Aaps Journal. 15: 523-32. PMID 23389812 DOI: 10.1208/S12248-013-9459-5 |
0.322 |
|
| 2013 |
Ma P, Rahima Benhabbour S, Feng L, Mumper RJ. 2'-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancer. Cancer Letters. 334: 253-62. PMID 22902506 DOI: 10.1016/J.Canlet.2012.08.009 |
0.457 |
|
| 2013 |
Feng L, Mumper RJ. A critical review of lipid-based nanoparticles for taxane delivery. Cancer Letters. 334: 157-75. PMID 22796606 DOI: 10.1016/J.Canlet.2012.07.006 |
0.5 |
|
| 2013 |
Madden AJ, Rawal S, Chu K, Sandison K, Schell R, Feng L, Ma P, Mumper R, DeSimone J, Zamboni WC. Abstract 3355: Evaluation of the efficiency of tumor and tissue delivery of carrier mediated agents (CMA) and small molecule (SM) agents in mice using a novel pharmacokinetic (PK) metric relative distribution index over time (RDI-OT). Cancer Research. 73: 3355-3355. DOI: 10.1158/1538-7445.Am2013-3355 |
0.341 |
|
| 2012 |
Minocha S, Mumper RJ. Effect of carbon coating on the physico-chemical properties and toxicity of copper and nickel nanoparticles. Small (Weinheim An Der Bergstrasse, Germany). 8: 3289-99. PMID 22837153 DOI: 10.1002/Smll.201200478 |
0.356 |
|
| 2012 |
Wadhwa S, Mumper RJ. Polypeptide conjugates of D-penicillamine and idarubicin for anticancer therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 158: 215-23. PMID 22063001 DOI: 10.1016/J.Jconrel.2011.10.027 |
0.345 |
|
| 2012 |
Benhabbour SR, Luft JC, Kim D, Jain A, Wadhwa S, Parrott MC, Liu R, DeSimone JM, Mumper RJ. In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain. Journal of Controlled Release : Official Journal of the Controlled Release Society. 158: 63-71. PMID 22037106 DOI: 10.1016/J.Jconrel.2011.10.013 |
0.4 |
|
| 2011 |
Feng L, Wu H, Ma P, Mumper RJ, Benhabbour SR. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo. International Journal of Nanomedicine. 6: 2545-56. PMID 22072889 DOI: 10.2147/Ijn.S24954 |
0.457 |
|
| 2011 |
Klauber-DeMore N, Fontenot E, Mumper R, Ma P, Rossi E, Siamakpour-Reihani S, Bone B, Hilliard E, Ketelsen D, Santos C, Patterson C. P3-16-04: A Novel Monoclonal Antibody to Secreted Frizzled Related Protein 2 Inhibits Triple Negative Breast Carcinoma Growth Rate In Vivo. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P3-16-04 |
0.301 |
|
| 2011 |
Zhu Q, Talton J, Zhang G, Cunningham T, Kirk J, Eppler B, Klinman DM, Belyakov IM, Sui Y, Gagnon S, Mumper RJ, Berzofsky JA. 139 A Novel Nanoparticle Approach to Induce Colorectal and Vaginal Mucosal Immunity Jaids Journal of Acquired Immune Deficiency Syndromes. 56: 56. DOI: 10.1097/01.Qai.0000397325.18998.79 |
0.435 |
|
| 2010 |
Jain A, Yan W, Miller KR, O'Carra R, Woodward JG, Mumper RJ. Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity. International Journal of Pharmaceutics. 401: 87-92. PMID 20837122 DOI: 10.1016/J.Ijpharm.2010.09.003 |
0.382 |
|
| 2010 |
Dong X, Mumper RJ. Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (London, England). 5: 597-615. PMID 20528455 DOI: 10.2217/Nnm.10.35 |
0.603 |
|
| 2010 |
Holpuch AS, Hummel GJ, Tong M, Seghi GA, Pei P, Ma P, Mumper RJ, Mallery SR. Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharmaceutical Research. 27: 1224-36. PMID 20354767 DOI: 10.1007/S11095-010-0121-Y |
0.489 |
|
| 2009 |
Yan W, Jain A, O'Carra R, Woodward JG, Li W, Li G, Nath A, Mumper RJ. Lipid Nanoparticles with Accessible Nickel as a Vaccine Delivery System for Single and Multiple His-tagged HIV Antigens. Hiv/Aids (Auckland, N.Z.). 2009: 1-11. PMID 21966230 DOI: 10.2147/Hiv.S5729 |
0.412 |
|
| 2009 |
Ma P, Dong X, Swadley CL, Gupte A, Leggas M, Ledebur HC, Mumper RJ. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. Journal of Biomedical Nanotechnology. 5: 151-61. PMID 20055093 DOI: 10.1166/Jbn.2009.1021 |
0.628 |
|
| 2009 |
Dong X, Mattingly CA, Tseng MT, Cho MJ, Liu Y, Adams VR, Mumper RJ. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Research. 69: 3918-26. PMID 19383919 DOI: 10.1158/0008-5472.Can-08-2747 |
0.65 |
|
| 2009 |
Dong X, Mattingly CA, Tseng M, Cho M, Adams VR, Mumper RJ. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization European Journal of Pharmaceutics and Biopharmaceutics. 72: 9-17. PMID 19111929 DOI: 10.1016/J.Ejpb.2008.11.012 |
0.676 |
|
| 2007 |
Patel JD, O'Carra R, Jones J, Woodward JG, Mumper RJ. Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens. Pharmaceutical Research. 24: 343-52. PMID 17180725 DOI: 10.1007/S11095-006-9154-7 |
0.479 |
|
| 2007 |
Patel JD, Gandhapudi S, Jones J, O'Carra R, Woodward JG, Mumper RJ. Cationic nanoparticles for delivery of CpG oligodeoxynucleotide and ovalbumin: In vitro and in vivo assessment Journal of Biomedical Nanotechnology. 3: 97-106. DOI: 10.1166/Jbn.2007.007 |
0.455 |
|
| 2007 |
Ravi Kumar MNV, Mumper RJ. A special issue on nanotechnology in advanced drug delivery Journal of Biomedical Nanotechnology. 3. DOI: 10.1166/Jbn.2007.001A |
0.338 |
|
| 2006 |
Koziara JM, Lockman PR, Allen DD, Mumper RJ. The blood-brain barrier and brain drug delivery. Journal of Nanoscience and Nanotechnology. 6: 2712-35. PMID 17048477 DOI: 10.1166/Jnn.2006.441 |
0.787 |
|
| 2006 |
Dong X, Mumper RJ. The metabolism of fatty alcohols in lipid nanoparticles by alcohol dehydrogenase. Drug Development and Industrial Pharmacy. 32: 973-80. PMID 16954110 DOI: 10.1080/03639040600640006 |
0.55 |
|
| 2006 |
Koziara JM, Whisman TR, Tseng MT, Mumper RJ. In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. 112: 312-9. PMID 16626835 DOI: 10.1016/J.Jconrel.2006.03.001 |
0.79 |
|
| 2006 |
Patel J, Galey D, Jones J, Ray P, Woodward JG, Nath A, Mumper RJ. HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant. Vaccine. 24: 3564-73. PMID 16516358 DOI: 10.1016/J.Vaccine.2006.01.065 |
0.379 |
|
| 2006 |
Egbert J, Geldenhuys W, Thomas F, Lockman PR, Mumper RJ, Allen DD. Nanoparticle Targeting for Drug Delivery Across the Blood-Brain Barrier Role of Lipid Excipients in Modifying Oral and Parenteral Drug Delivery: Basic Principles and Biological Examples. 160-169. DOI: 10.1002/9780470097984.ch6 |
0.463 |
|
| 2005 |
Koziara JM, Oh JJ, Akers WS, Ferraris SP, Mumper RJ. Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharmaceutical Research. 22: 1821-8. PMID 16132346 DOI: 10.1007/S11095-005-7547-7 |
0.817 |
|
| 2005 |
Cui Z, Lockman PR, Atwood CS, Hsu CH, Gupte A, Allen DD, Mumper RJ. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fã¼R Pharmazeutische Verfahrenstechnik E.V. 59: 263-72. PMID 15661498 DOI: 10.1016/J.Ejpb.2004.07.009 |
0.438 |
|
| 2004 |
Lockman PR, Koziara JM, Mumper RJ, Allen DD. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. Journal of Drug Targeting. 12: 635-41. PMID 15621689 DOI: 10.1080/10611860400015936 |
0.802 |
|
| 2004 |
Koziara JM, Lockman PR, Allen DD, Mumper RJ. Paclitaxel nanoparticles for the potential treatment of brain tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. 99: 259-69. PMID 15380635 DOI: 10.1016/J.Jconrel.2004.07.006 |
0.816 |
|
| 2004 |
Cui Z, Patel J, Tuzova M, Ray P, Phillips R, Woodward JG, Nath A, Mumper RJ. Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. Vaccine. 22: 2631-40. PMID 15193389 DOI: 10.1016/J.Vaccine.2003.12.013 |
0.437 |
|
| 2004 |
Weekley JC, Wuenschel S, Rosenstiel PE, Mumper RJ, Jay M. Aqueous liquid scintillation counting with fluor-containing nanosuspensions. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 60: 887-91. PMID 15110354 DOI: 10.1016/J.Apradiso.2004.01.014 |
0.443 |
|
| 2004 |
Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. 95: 613-26. PMID 15023471 DOI: 10.1016/J.Jconrel.2004.01.002 |
0.779 |
|
| 2003 |
Koziara JM, Lockman PR, Allen DD, Mumper RJ. In situ blood-brain barrier transport of nanoparticles. Pharmaceutical Research. 20: 1772-8. PMID 14661921 DOI: 10.1023/B:Pham.0000003374.58641.62 |
0.817 |
|
| 2003 |
Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD. Brain uptake of thiamine-coated nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 93: 271-82. PMID 14644577 DOI: 10.1016/J.Jconrel.2003.08.006 |
0.805 |
|
| 2003 |
Hsu CH, Cui Z, Mumper RJ, Jay M. Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. Aaps Pharmscitech. 4: E32. PMID 14621964 DOI: 10.1208/Pt040332 |
0.545 |
|
| 2003 |
Cui Z, Mumper RJ. Microparticles and nanoparticles as delivery systems for DNA vaccines. Critical Reviews in Therapeutic Drug Carrier Systems. 20: 103-37. PMID 14584521 DOI: 10.1615/Critrevtherdrugcarriersyst.V20.I23.10 |
0.318 |
|
| 2003 |
Mumper RJ, Cui Z. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Methods (San Diego, Calif.). 31: 255-62. PMID 14511958 DOI: 10.1016/S1046-2023(03)00138-5 |
0.436 |
|
| 2003 |
Cui Z, Hsu CH, Mumper RJ. Physical characterization and macrophage cell uptake of mannan-coated nanoparticles. Drug Development and Industrial Pharmacy. 29: 689-700. PMID 12889787 DOI: 10.1081/Ddc-120021318 |
0.547 |
|
| 2003 |
Lockman PR, Mumper RJ, Allen DD. Evaluation of blood-brain barrier thiamine efflux using the in situ rat brain perfusion method Journal of Neurochemistry. 86: 627-634. PMID 12859676 DOI: 10.1046/J.1471-4159.2003.01888.X |
0.363 |
|
| 2003 |
Lockman PR, Koziara J, Roder KE, Paulson J, Abbruscato TJ, Mumper RJ, Allen DD. In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles. Pharmaceutical Research. 20: 705-13. PMID 12751624 DOI: 10.1023/A:1023492015851 |
0.816 |
|
| 2003 |
Cui Z, Baizer L, Mumper RJ. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device. Journal of Biotechnology. 102: 105-15. PMID 12697387 DOI: 10.1016/S0168-1656(03)00029-4 |
0.474 |
|
| 2003 |
Oyewumi MO, Liu S, Moscow JA, Mumper RJ. Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters. Bioconjugate Chemistry. 14: 404-11. PMID 12643751 DOI: 10.1021/Bc0340013 |
0.77 |
|
| 2003 |
Cui Z, Mumper RJ. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 55: 11-8. PMID 12551699 DOI: 10.1016/S0939-6411(02)00129-7 |
0.437 |
|
| 2003 |
Oyewumi MO, Mumper RJ. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. International Journal of Pharmaceutics. 251: 85-97. PMID 12527178 DOI: 10.1016/S0378-5173(02)00587-2 |
0.785 |
|
| 2003 |
Mumper RJ, Cui Z, Oyewumi MO. Nanotemplate engineering of cell specific nanoparticles Journal of Dispersion Science and Technology. 24: 569-588. DOI: 10.1081/Dis-120021814 |
0.764 |
|
| 2002 |
Oyewumi MO, Mumper RJ. Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy. Bioconjugate Chemistry. 13: 1328-35. PMID 12440870 DOI: 10.1021/Bc025560X |
0.783 |
|
| 2002 |
Cui Z, Mumper RJ. Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation. Bioconjugate Chemistry. 13: 1319-27. PMID 12440869 DOI: 10.1021/Bc0255586 |
0.559 |
|
| 2002 |
Cui Z, Mumper RJ. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses. The Journal of Pharmacy and Pharmacology. 54: 1195-203. PMID 12356273 DOI: 10.1211/002235702320402035 |
0.487 |
|
| 2002 |
Cui Z, Mumper RJ. Genetic immunization using nanoparticles engineered from microemulsion precursors. Pharmaceutical Research. 19: 939-46. PMID 12180545 DOI: 10.1023/A:1016402019380 |
0.493 |
|
| 2002 |
Oyewumi MO, Mumper RJ. Gadolinium-loaded nanoparticles engineered from microemulsion templates. Drug Development and Industrial Pharmacy. 28: 317-28. PMID 12026224 DOI: 10.1081/Ddc-120002847 |
0.783 |
|
| 2002 |
Cui Z, Mumper RJ. Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. International Journal of Pharmaceutics. 238: 229-39. PMID 11996826 DOI: 10.1016/S0378-5173(02)00079-0 |
0.479 |
|
| 2002 |
Cui Z, Mumper RJ. Topical immunization using nanoengineered genetic vaccines. Journal of Controlled Release : Official Journal of the Controlled Release Society. 81: 173-84. PMID 11992690 DOI: 10.1016/S0168-3659(02)00051-2 |
0.465 |
|
| 2002 |
Lockman PR, Mumper RJ, Khan MA, Allen DD. Nanoparticle technology for drug delivery across the blood-brain barrier Drug Development and Industrial Pharmacy. 28: 1-13. PMID 11858519 DOI: 10.1081/Ddc-120001481 |
0.518 |
|
| 2001 |
Cui Z, Mumper RJ. Chitosan-based nanoparticles for topical genetic immunization Journal of Controlled Release. 75: 409-419. PMID 11489327 DOI: 10.1016/S0168-3659(01)00407-2 |
0.525 |
|
| Show low-probability matches. |